PFL-721
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PFL-721, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations [Phase 1, Phase 2]